Scientific Advisory Board

Our pipeline is built on exceptional scientific rigor, guided by the critical assessment of world-class key opinion leaders in pediatric oncology who devote their profound expertise and commitment to shape our strategic therapeutic decisions.

  • Peter Adamson, MD, PhD

    Former Chair at Chidren’s Oncology Group and Global Head, Oncology Development & Pediatric Innovation at Sanofi

    Linkedin

  • Pratiti Bandopadhayay, MBBS, PhD

    Pediatric Neuro-Oncologist at Dana Farber Cancer Institute

    Linkedin

  • Steven Dubois, MD, MS

    Director, Experimental Therapeutics at Dana Farber Cancer Institute

    Linkedin

  • Juliet Gray, MD, MA, MBBS, MRCPCH, PhD

    Clinical Lead Pediatric Oncology at Southampton Pediatric Oncology Centre

    Linkedin

  • Lee J. Helman, MD

    Director of the Osteosarcoma Institute

    About

  • Daniel Morgenstern, MD, PhD

    Clinical Trials Lead Pediatric Oncology at Sickkids Toronto

    LinkedIn